Articles
March 14, 2023
HTL team in Korea and China
The primary objective of our visit in Korea and China was to engage with our existing clients, forge new business relationships, and explore opportunities for expanding our market presence in these regions.
HTL was pleased to share the latest news from its team, who were in Asia to expand the company’s business in the region.
HTL was delighted by the warm welcome that its team and products received, first in Korea and then in China.
To see our most recent news,
Read more
news from us
-
Articles July 5, 2024HTL Biotechnology Secures Medical Device Registration in China
Sodium DNA Raw Material Main Document (Polynucleotides) registered as a medical device (number M2024199-000) in China.
-
Articles June 21, 2024HTL Biotechnology at CPHI China 2024
CPHI China is one of Asia’s leading Pharma events for trading and networking with 3,500+ exhibitors and 90,000+ professionals from the pharmaceutical industry,
-
Articles June 13, 2024Discover our Quality Policy
At HTL Biotechnology, we believe in going beyond together to achieve the highest quality standards.